Desai et al. (2022) compared incidence of Alzheimer’s disease and related dementia (ADRD) after PDE5 inhibitor initiation versus endothelin receptor (ET) antagonist initiation among patients with pulmonary hypertension [64]. This evidence concerns the gene PDE5A and Alzheimer disease.